OOIR: Observatory of International Research

Papers

(The median citation count of Endocrine Reviews is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	648
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	311
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	237
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future	236
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	215
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	196
DNA Damage and Repair in Thyroid Physiology and Disease	181
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	133
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	133
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	131
The Molecular Biology of Midgut Neuroendocrine Neoplasms	121
Effects of Maternal Vitamin D Supplementation on Childhood Health	119
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity	116
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	111
Calcium-sensing receptor regulation of gastrointestinal hormone secretion	94
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	93
The Biology and Clinical Implications of PCSK7	90
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	89
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	84
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	75
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	74
Estrogen Receptor Signaling in the Immune System	72
Contemporary Biological Insights and Clinical Management of Craniopharyngioma	70
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	69
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”	68

Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	64
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	63
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	62
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	60
The Metabolic Role and Therapeutic Potential of the Microbiome	60
Adiponectin and Adiponectin Receptors in Atherosclerosis	57
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases	55
The Cortisol Awakening Response: Regulation and Functional Significance	55
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	54
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	52
Imaging of Pheochromocytomas and Paragangliomas	49
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease	48
Molecular and Clinical Spectrum of Primary Hyperparathyroidism	48
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	48
Brown Adipose Tissue—A Translational Perspective	47
G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities	45
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications	45
Erratum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	44
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy	43
Protective Factors and the Pathogenesis of Complications in Diabetes	43
Endocrine Controls of Skin Aging	41
Medullary Thyroid Cancer: Updates and Challenges	41
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease	41
Retraction and Replacement of: “Effects of Maternal Vitamin D Supplementation on Childhood Health”	39
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management	38
Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency	37
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification	37
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?	37
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma	36
Teprotumumab for the Treatment of Thyroid Eye Disease	35
Update on Adipose Tissue and Cancer	34
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision	31
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia	31
Crosstalk Between the Neuroendocrine System and Bone Homeostasis	30
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement	29
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications	29
A Clinical Update on Gestational Diabetes Mellitus	29
Corrigendum to: The Role of Iodine for Thyroid Function in Lactating Women and Infants	28
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens	25
Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis	24
Corrigendum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment	24
Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies	24
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice	23
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy	23
Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications	23
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease	22
Endocrine Dysfunction in Primary Mitochondrial Diseases	22
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome	21
Peptidergic G Protein–Coupled Receptor Regulation of Adrenal Function: Bench to Bedside and Back	20
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease	20